This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Ruprecht-Karls-Universitat Heidelberg. Active years: 2011-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2011-2015
Title: R Heiner Schirmer: Innovator in Pharmaceutical Chemistry
Introduction
R Heiner Schirmer is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 2 patents, Schirmer's work focuses on the development of therapeutic compounds with potential medical applications.
Latest Patents
Among his latest patents, Schirmer has developed 1,4-naphthoquinones derivatives and their therapeutic use. This invention involves compounds of formula (I) wherein A is selected from various rings, emphasizing their preparation and application as antimalarial agents. Another significant patent involves phosphole derivatives complexed with metals, which concerns pharmaceutical compositions comprising at least one compound of general formula (A). This invention aims to prevent or treat pathologies associated with excess activity of glutathione reductase and/or thioredoxin reductase.
Career Highlights
Throughout his career, Schirmer has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Ruprecht-Karls-Universität Heidelberg. His experience in these organizations has contributed to his expertise in pharmaceutical research and development.
Collaborations
Some of his notable coworkers include Elisabeth Davioud-Charvet and Katja Becker-Brandenburg. Their collaborative efforts have further advanced the research and applications of the compounds developed by Schirmer.
Conclusion
R Heiner Schirmer's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a significant inventor in the field. His work continues to influence the development of therapeutic agents that may benefit various medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile